Solasta Ventures
Home Approach Portfolio
News Team Hatchery Contact
HomeApproachPortfolio
Solasta Ventures
NewsTeamHatcheryContact
Arcellx Raises $85 Million in a Series B Financing to Advance its Intelligent Cell Therapy Platform
Nia JulianOctober 3, 2019
Facebook0 Twitter Pinterest0 0 Likes
Previous

Arvinas Presents a Platform Update, Including Initial Data from the First Two Clinical Trials of PROTAC® Targeted Protein Degraders

Nia JulianOctober 23, 2019
Next

G1 Therapeutics Presents First Clinical Data on Oral SERD G1T48 Demonstrating Safety and Tolerability in Patients with Advanced Breast Cancer at ESMO 2019

Nia JulianSeptember 29, 2019

© 2020 Solasta Ventures. All Rights Reserved.